Valeurs | |||||
Le rangement donne un aperçu de toutes les valeurs mobilières classées de manière alphabétique ou selon les indices. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Nom | Code | Analysis date | Cours de clôture | +/- % |
Nektar Therapeutics | ITH | 2. avr 2025 | 0.58 | -6.48 |
NEL | D7G | 2. avr 2025 | 0.21 | -4.41 |
Nel ASA Unsponsored ADR (Norway) | D7GA | 2. avr 2025 | 5.85 | -6.40 |
Nelly Group | CD20 | 2. avr 2025 | 2.94 | -0.84 |
Nelnet, Inc. | NIJ | 2. avr 2025 | 101.00 | -0.98 |
NEMETSCHEK UNSP.ADR/0,2 | NEM0 | 2. avr 2025 | 20.20 | +1.51 |
Nemetschek SE | NEM | 2. avr 2025 | 107.30 | -0.92 |
NENT Group B | NEB | 2. avr 2025 | 0.05 | +5.73 |
Neo Performance Materials Inc | N14 | 2. avr 2025 | 5.55 | +3.35 |
NEO-NEON | N2L | 2. avr 2025 | 0.04 | +1.23 |
Neodecortech S.p.a. | FM2 | 2. avr 2025 | 2.84 | +1.43 |
Neoen S.A. | N1N | 2. avr 2025 | 38.70 | 0.00 |
NEOENERGIA UNSP.ADR 1 | 2Q40 | 2. avr 2025 | 13.10 | 0.00 |
Neogen Corporation | NG2 | 2. avr 2025 | 7.80 | -1.89 |
NeoGenomics, Inc. | NG9 | 2. avr 2025 | 8.55 | -1.16 |
Neolife | 8JB | 2. avr 2025 | 0.07 | -6.07 |
Neometals Ltd | 9R9 | 2. avr 2025 | 0.04 | +2.27 |
NEOMETALS LTD SP.ADS/10 | 9R91 | 2. avr 2025 | 0.24 | -3.20 |
NEON EQUITY NA O.N. | D77 | 2. avr 2025 | 2.70 | 0.00 |
NeonMind Biosciences Inc | 6UF0 | 2. avr 2025 | 0.00 | -90.00 |
Neosperience S.p.a | Y8E | 2. avr 2025 | 0.47 | 0.00 |
NEOTECH METALS CORP. | V690 | 2. avr 2025 | 0.08 | -35.66 |
NeoVolta | 4EB | 2. avr 2025 | 2.04 | 0.00 |
Nephros | NPJP | 2. avr 2025 | 1.65 | +5.10 |
Neptune Digital Assets Corp. | 1NW | 2. avr 2025 | 0.99 | -0.60 |
Nerds On Site Inc | 3NS | 2. avr 2025 | 0.02 | 0.00 |
Nerdwallet Inc | 6OI | 2. avr 2025 | 8.70 | +1.16 |
NervGen Pharma Corp | 9UA | 2. avr 2025 | 1.80 | +8.43 |
Neste | NEF | 2. avr 2025 | 8.36 | +0.58 |
Neste OYJ American Depositary Receipts - Unsponsored | NEFA | 2. avr 2025 | 4.00 | -1.48 |
|
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.